Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK2 | O60674 | 17/20 | 1.00 |
| ▸ | CHEK1 | O14757 | 4/20 | 1.00 |
| ▸ | JAK3 | P52333 | 3/20 | 1.00 |
| ▸ | JAK1 | P23458 | 2/20 | 1.00 |
| ▸ | TYK2 | P29597 | 2/20 | 1.00 |
| ▸ | IKBKB | O14920 | 1/20 | 1.00 |
| ▸ | MAPK13 | O15264 | 1/20 | 1.00 |
| ▸ | DAPK3 | O43293 | 1/20 | 1.00 |
| ▸ | PRKD3 | O94806 | 1/20 | 1.00 |
| ▸ | FYN | P06241 | 1/20 | 1.00 |
| ▸ | RET | P07949 | 1/20 | 1.00 |
| ▸ | HCK | P08631 | 1/20 | 1.00 |
| ▸ | PDGFRB | P09619 | 1/20 | 1.00 |
| ▸ | PIM1 | P11309 | 1/20 | 1.00 |
| ▸ | FGFR1 | P11362 | 1/20 | 1.00 |
| ▸ | PDGFRA | P16234 | 1/20 | 1.00 |
| ▸ | PRKCA | P17252 | 1/20 | 1.00 |
| ▸ | PRKACA | P17612 | 1/20 | 1.00 |
| ▸ | FLT1 | P17948 | 1/20 | 1.00 |
| ▸ | FGFR2 | P21802 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29521847 | 0.95 | JAK2 (0.91) | JAK2CHEK1JAK3JAK1TYK2 | |
| SCHEMBL904545 | 0.95 | JAK2 (0.91) | JAK2CHEK1JAK3JAK1TYK2 | |
| SCHEMBL13741485 | 0.83 | JAK2 (0.71) | JAK2CHEK1JAK3JAK1TYK2 | |
| SCHEMBL5759753 | 0.81 | JAK2 (0.68) | JAK2CHEK1JAK3JAK1TYK2 | |
| SCHEMBL3311115 | 0.81 | JAK2 (0.67) | JAK2CHEK1JAK3JAK1TYK2 | |
| SCHEMBL5761824 | 0.80 | JAK2 (0.66) | JAK2CHEK1JAK3JAK1TYK2 | |
| SCHEMBL5759495 | 0.79 | JAK2 (0.65) | JAK2CHEK1JAK3JAK1TYK2 | |
| SCHEMBL2304822 | 0.78 | JAK2 (0.64) | JAK2CHEK1JAK3JAK1TYK2 | |
| SCHEMBL4099738 | 0.77 | JAK2 (0.63) | JAK2CHEK1JAK3JAK1TYK2 | |
| SCHEMBL2305886 | 0.77 | JAK2 (0.62) | JAK2CHEK1JAK3JAK1TYK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 186 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115207999-B | Multi-fast charge protocol control circuit, control method, related chip and electronic equipment | Shenzhen yingjixin Technology Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | claimed |
| EP-4697578-A1 | SINGLE-INDUCTOR MULTIPLE-OUTPUT VOLTAGE CONVERTER, POWER SUPPLY CHIP, AND ELECTRONIC DEVICE | Telink Semiconductor (Shanghai) Co., Ltd. (CN) | 2026-02-18 | — | — | EP | claimed |
| CN-118349076-A | Rapid MPPT method based on power detection and quantification for radio frequency energy acquisition | 西安电子科技大学重庆集成电路创新研究院 | 2024-07-16 | — | — | CN | claimed |
| CN-117767790-A | Synchronous management circuit for piezoelectric vibration energy collection and power supply | 西安电子科技大学 | 2024-03-26 | — | — | CN | claimed |
| CN-116829707-A | Method for improving fixed point integration frequency | 孟山都技术公司 | 2023-09-29 | — | — | CN | claimed |
| CN-116301140-A | Reference current source | 中国科学技术大学 | 2023-06-23 | — | — | CN | claimed |
| CN-115207999-A | Multi-quick-charging-protocol control circuit, control method, related chip and electronic equipment | 深圳英集芯科技股份有限公司 | 2022-10-18 | — | — | CN | claimed |
| WO-2022214083-A1 | MULTI-FAST CHARGING PROTOCOL CONTROL CIRCUIT, CONTROL METHOD, CHIP, AND ELECTRONIC DEVICE | 深圳英集芯科技股份有限公司 | 2022-10-13 | — | — | WO | claimed |
| US-20220184217-A1 | HSP90-BINDING CONJUGATES AND FORMULATIONS THEREOF | Fusion Pharmaceuticals Inc. (CA) | 2022-06-16 | — | — | US | claimed |
| EP-3946320-A1 | HSP90-BINDING CONJUGATES AND FORMULATIONS THEREOF | Tarveda Therapeutics, Inc. (US) | 2022-02-09 | — | — | EP | claimed |
| CN-115207999-B | Multi-fast charge protocol control circuit, control method, related chip and electronic equipment | Shenzhen yingjixin Technology Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | disclosed |
| US-12627224-B2 | Resonant power convertor and control method thereof | RICHTEK TECHNOLOGY CORPORATION (TW) | 2026-05-12 | — | — | US | disclosed |
| US-20260121528-A1 | RESONANT POWER CONVERSION CIRCUIT AND DRIVING METHOD THEREOF FOR ELIMINATING AUDIO NOISE | RICHTEK TECHNOLOGY CORP (TW) | 2026-04-30 | — | — | US | disclosed |
| US-12610793-B2 | Method of manufacturing memory device | MACRONIX INTERNATIONAL CO., LTD. (TW) | 2026-04-21 | — | — | US | disclosed |
| US-12590963-B2 | Anti-cancer treatment of preselected subjects and screening methods to identify susceptible subjects | TUDAG TU DRESDEN AKTIENGESELLSCHAFT (DE) | 2026-03-31 | — | — | US | disclosed |
| US-20180214449-A1 | CANCER THERAPY USING JAK INHIBITOR IN COMBINATION WITH MAPK INHIBITORS | UBRX, INC. | 2018-08-02 | — | — | US | disclosed |
| US-7919261-B2 | Methods for predicting treatment response based on the expression profiles of protein and transcription biomarkers | MERCK SHARP & DOHME CORP. (US) | 2011-04-05 | — | — | US | disclosed |
| US-20090304594-A1 | Methods for Predicting Treatment Response Based On the Expression Profiles of Protein and Transcription Biomarkers | MERCK SHARP & DOHME CORP. | 2009-12-10 | — | — | US | disclosed |
| US-7593820-B2 | Crystal structure of human Janus Kinase 2 (JAK2) and uses thereof | CYTOPIA RESEARCH PTY LTD (AU) | 2009-09-22 | — | — | US | disclosed |
| US-7593820-B2 | Crystal structure of human Janus Kinase 2 (JAK2) and uses thereof | CYTOPIA RESEARCH PTY LTD (AU) | 2009-09-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260121528-A1 | RESONANT POWER CONVERSION CIRCUIT AND DRIVING METHOD THEREOF FOR ELIMINATING AUDIO NOISE | FCER2, TMCO1, CRY1 | JAK2 3040/4885CHEK1 1634/4885JAK3 1582/4885 |
| US-20220184217-A1 | HSP90-BINDING CONJUGATES AND FORMULATIONS THEREOF | HSP90AB1, HSP90B1, HSP90AA1 | JAK2 3694/4885CHEK1 1882/4885JAK3 4711/4885 |
| US-12610793-B2 | Method of manufacturing memory device | PIEZO1, MEF2D, SMCHD1 | JAK2 3272/4885CHEK1 453/4885JAK3 772/4885 |
| US-12627224-B2 | Resonant power convertor and control method thereof | RCOR1, RCOR3, TRRAP | JAK2 865/4885CHEK1 1231/4885JAK3 724/4885 |
| US-20180214449-A1 | CANCER THERAPY USING JAK INHIBITOR IN COMBINATION WITH MAPK INHIBITORS | JAK2, JAK1, JAK3 | JAK2 1/4885CHEK1 156/4885JAK3 3/4885 |
| US-12590963-B2 | Anti-cancer treatment of preselected subjects and screening methods to identify susceptible subjects | TPM4, TPM3, TAGLN2 | JAK2 3979/4885CHEK1 1136/4885JAK3 1863/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.